Claudia Mendoza‐Pinto

ORCID: 0000-0002-5101-7705
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Systemic Lupus Erythematosus Research
  • Atherosclerosis and Cardiovascular Diseases
  • Systemic Sclerosis and Related Diseases
  • Diabetes and associated disorders
  • Spondyloarthritis Studies and Treatments
  • Vitamin D Research Studies
  • T-cell and B-cell Immunology
  • Rheumatoid Arthritis Research and Therapies
  • Liver Diseases and Immunity
  • Monoclonal and Polyclonal Antibodies Research
  • Cervical Cancer and HPV Research
  • COVID-19 Clinical Research Studies
  • Adrenal Hormones and Disorders
  • Dermatological and COVID-19 studies
  • Celiac Disease Research and Management
  • Vasculitis and related conditions
  • Long-Term Effects of COVID-19
  • Lymphoma Diagnosis and Treatment
  • Thyroid Disorders and Treatments
  • Cytokine Signaling Pathways and Interactions
  • Helicobacter pylori-related gastroenterology studies
  • Bone and Joint Diseases
  • Platelet Disorders and Treatments
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Autoimmune and Inflammatory Disorders Research

Benemérita Universidad Autónoma de Puebla
2016-2025

Mexican Social Security Institute
2016-2025

Hospital de Especialidades
2018-2024

Sociedad Española de Medicina Interna
2007-2014

Hospital Clínic de Barcelona
2012

Hospital Universitario Infantil San José
2007

The objective of this study was to investigate the efficacy and safety anti-CD20 treatment in Hispanic patients with refractory systemic lupus erythematosus determine whether baseline parameters predict disease flare. Fifty-two erythematosus, 13 active nephritis, eight thrombocytopenia, three leukocytopenia, 25 severe musculoskeletal involvement skin involvement) conventional therapy were treated (rituximab; MabThera ® , Roche) plus ongoing immunosuppressive treatment. Disease activity...

10.1177/0961203309351541 article EN Lupus 2009-12-04

Objective To assess the accuracy, completeness, and reproducibility of Large Language Models (LLMs) (Copilot, GPT-3.5, GPT-4) on antimalarial use in systemic lupus erythematosus (SLE). Materials Methods We utilized 13 questions derived from patient surveys common inquiries National Health Service. Two independent rheumatologists assessed responses LLMs using predefined Likert scales for reproducibility. Results The GPT models Copilot achieved high scores accuracy. However, completeness...

10.1177/09612033251324501 article EN Lupus 2025-02-27

Patients with polymyositis and dermatomyositis (PM/DM) are prone to multiple complications that may lead increased mortality rates. Data about PM/DM in Mexico lacking. The aim of this study was assess trends across 2 decades (2000-2019), overall, by sex, age group, geographic region. From 2000 2019, deaths were identified Mexican open-access health databases using the International Classification Diseases, 10th Revision. Age-standardized rates (ASMRs) per 100,000 inhabitants calculated for...

10.1097/rhu.0000000000002211 article EN PubMed 2025-03-12

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis entails substantial morbidity and mortality, yet no epidemiologic evidence exists on its outcomes in Mexico. This study assessed national hospitalizations (2005 to 2022) mortality (2000 related ANCA-associated using data from the General Board of Health Information. We extracted hospital discharges deaths classified under ICD-10 M31.3 M31.7, computing age-standardized hospitalization (ASHR) (ASMR) rates per 100,000 persons,...

10.1101/2025.03.13.25323860 preprint EN cc-by-nd medRxiv (Cold Spring Harbor Laboratory) 2025-03-14

Autoimmune diseases (ADs) pose a significant health burden among adolescents and young adults (AYAs) in Mexico. However, comprehensive national epidemiological data remain limited. This study evaluates the prevalence, incidence, mortality of six major AD: rheumatoid arthritis (RA), inflammatory bowel disease (IBD), multiple sclerosis (MS), type 1 diabetes mellitus (T1DM), asthma, psoriasis, utilizing from Global Burden Disease Study 2021. Age-standardized rates were calculated through direct...

10.1101/2025.04.04.25325208 preprint EN cc-by-nc medRxiv (Cold Spring Harbor Laboratory) 2025-04-05

Health-related quality of life (HRQOL) is affected by numerous clinical variables, including disease activity, damage, fibromyalgia, depression and anxiety. However, these associations have not yet been described in Mexican patients with systemic lupus erythematosus (SLE).To evaluate the relationship between fibromyalgia HRQOL measured LupusQoL-instrument SLE.A cross-sectional study was conducted women fulfilling 1997 ACR classification criteria for SLE. evaluated using a disease-specific...

10.1371/journal.pone.0170209 article EN cc-by PLoS ONE 2017-01-23
Coming Soon ...